semaglutide news november 28 2025 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025, the weekly dose of the GLP-1 agonist transformed him. This past March, when he decided to stop, his cravings returned — for Eli Lilly, Novo Nordisk near

For instance, women on hormone therapy shed approximately 35% more weight with tirzepatide than those who did not

Semaglutide (sold as Ozempic and Wegovy) is the most direct comparison, and understanding how their dosing schedules differ helps contextualize where tirzepatide fits in the broader landscape of GLP-1 receptor agonist therapy

Saxenda (a liraglutide) You may not have heard of Saxenda, but this is an approved weight loss management drug that regulates hunger and calorie intake through its GLP-1 receptor agonist (like Wegovy and Ozempic)

With Ozempic, which has the same active ingredient as Wegovy semaglutide 22.2% of patients kept filling their prescriptions at two years, down from 47.1% who had used it for one year

The conventional explanation for GLP-1-related skin laxity has been mechanical: you lose a significant volume of fat relatively quickly, and skin, which was previously stretched to accommodate that volume, does not always retract fully, leaving loose or lax tissue behind

Choose a competitor if you need insurance billing, brand-name medication options, structured coaching, or more established patient reviews to evaluate